Charles Schwab insider Beatty executes option exercise and 10b5-1 sales in August 2025
Rhea-AI Filing Summary
Jonathan S. Beatty, MD, Head of Advisor Services at The Charles Schwab Corporation (SCHW), reported option exercise and related sales in late August 2025. On 08/27/2025 he sold 3,296 shares at $97.18, leaving 11,923 shares reported as beneficially owned indirectly via a trust. On 08/28/2025 he exercised a nonqualified stock option with exercise price $46.39 for 6,144 shares, and those 6,144 shares were contributed to a trust per the form. The same day he sold 6,144 shares under a Rule 10b5-1 trading plan (adopted Feb 28, 2024) at a weighted average sale price of $96.8113. The option referenced was granted under the company’s 2013 Stock Incentive Plan and vested in four equal annual installments.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine option exercise and sales under a 10b5-1 plan; no new information on company operations or financials.
The filing documents a common insider activity: exercise of a nonqualified option at a $46.39 strike and immediate sales executed under a pre-established Rule 10b5-1 plan on 08/28/2025. The sales were executed at a weighted average price of $96.8113 and a separate sale on 08/27/2025 was at $97.18. These transactions change the reporting person’s direct/indirect holdings as recorded but do not disclose company financial performance or governance changes.
TL;DR: Disclosure follows standard Section 16 reporting for option exercise and planned sales; appropriate use of 10b5-1 noted.
The form indicates adherence to disclosure rules and use of an established Rule 10b5-1 trading plan (adopted 02/28/2024). It also notes the option was granted under the 2013 Stock Incentive Plan and vesting terms are clarified. The filing is procedural and documents beneficial ownership shifts (including contribution to a trust) rather than governance actions or departures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Nonqualified Stock Option (right to buy) | 6,144 | $0.00 | -- |
| Exercise | Common Stock | 6,144 | $46.39 | $285K |
| Sale | Common Stock | 6,144 | $96.8113 | $595K |
| Sale | Common Stock | 3,296 | $97.18 | $320K |
Footnotes (1)
- Reflects the contribution of 6,144 shares received upon exercise of the option to a trust. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. This transaction was executed in multiple trades at prices ranging from $96.55 to $97.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.